Valicenti Advisory Services Inc Lowers stake in Intuitive Surgical (ISRG)

Intuitive Surgical (ISRG) : Valicenti Advisory Services Inc reduced its stake in Intuitive Surgical by 0.75% during the most recent quarter end. The investment management company now holds a total of 6,655 shares of Intuitive Surgical which is valued at $4,545,897 after selling 50 shares in Intuitive Surgical , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Intuitive Surgical makes up approximately 2.79% of Valicenti Advisory Services Inc’s portfolio.

Other Hedge Funds, Including , Canandaigua National Bank Trust Co reduced its stake in ISRG by selling 25 shares or 1.41% in the most recent quarter. The Hedge Fund company now holds 1,745 shares of ISRG which is valued at $1,191,975. Intuitive Surgical makes up approx 0.34% of Canandaigua National Bank Trust Co’s portfolio.British Columbia Investment Management Corp reduced its stake in ISRG by selling 257 shares or 1.2% in the most recent quarter. The Hedge Fund company now holds 21,100 shares of ISRG which is valued at $14,323,524. Intuitive Surgical makes up approx 0.12% of British Columbia Investment Management Corp’s portfolio.

Intuitive Surgical opened for trading at $690 and hit $697.14 on the upside on Friday, eventually ending the session at $695.76, with a gain of 0.82% or 5.67 points. The heightened volatility saw the trading volume jump to 2,74,901 shares. Company has a market cap of $26,782 M.

On the company’s financial health, Intuitive Surgical reported $5.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.63 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $4.99. The company had revenue of $670.10 million for the quarter, compared to analysts expectations of $642.46 million. The company’s revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.57 EPS.

Many Wall Street Analysts have commented on Intuitive Surgical. Northland Capital Downgraded Intuitive Surgical on Jul 21, 2016 to ” Under Perform”, Price Target of the shares are set at $600.Company shares were Reiterated by Wedbush on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 755 from a previous price target of $715 .Company shares were Reiterated by Canaccord Genuity on Jul 20, 2016 to “Buy”, Firm has raised the Price Target to $ 750 from a previous price target of $700 .

Intuitive Surgical Inc. designs manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control range of motion tissue manipulation and three-dimensional (3-D) high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System the da Vinci Si Surgical System the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery gynecologic surgery general surgery cardiothoracic surgery and head and neck surgery.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *